Chemistry:Ro 04-6790

From HandWiki
Short description: Chemical compound
Ro 04-6790
Ro 04-6790.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ChEMBL
Chemical and physical data
FormulaC12H16N6O2S
Molar mass308.36 g·mol−1
3D model (JSmol)
  (verify)

Ro 04-6790 is a drug, developed by Hoffmann–La Roche, which has applications in scientific research. It acts as a potent and selective receptor antagonist for the 5-HT6 serotonin receptor subtype, with little or no affinity at other receptors. In common with other drugs of this class,[1] Ro 04-6790 has nootropic effects in animals,[2] and reduces the amnesia produced by memory-impairing drugs such as dizocilpine[3] and scopolamine.[4]

References

  1. "An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function". Neuropharmacology 55 (6): 1015–22. November 2008. doi:10.1016/j.neuropharm.2008.06.061. PMID 18655798. 
  2. "Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task". Psychopharmacology 202 (1–3): 111–23. January 2009. doi:10.1007/s00213-008-1334-1. PMID 18839151. 
  3. "The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801". Behavioural Brain Research 188 (2): 304–9. April 2008. doi:10.1016/j.bbr.2007.11.010. PMID 18164078. 
  4. "Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790". Psychopharmacology 170 (4): 358–67. December 2003. doi:10.1007/s00213-003-1552-5. PMID 13680084. http://doc.rero.ch/record/317786/files/213_2003_Article_1552.pdf.